geha semaglutide TrimRX GLP-1s | AgelessRx

12 The Timeline: For most people, these side effects are most pronounced during the first few weeks or months of treatment

This approval, along with its existing indications for adults with type 2 diabetes to improve glycemic control and to reduce the risk of major cardiovascular events in adults also with known heart disease, establishes Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg as the most broadly indicated glucagon-like peptide-1 receptor agonist (GLP-1 RA) in its class

WE ARE LOUISIANA

Clinicians awareness of and familiarity with this technology will enhance its accessibility for patients with diabetes